Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting ‘Trailblazers’ needed to combat the agonizing scourge of addiction By Krista Armstrong October 20, 2016 Tales from the Road – Orphan Drugs Summit in Amsterdam By Juliet Moritz October 14, 2016 Consulting Developing & Negotiating a Study Budget By Daryl Fallon October 4, 2016 Consulting The Importance of Study Team Experience By Daryl Fallon August 31, 2016 Clinical ResearchPhase 1 - Phase 4 Getting It Right from the Start: Applying QbD to Rare Disease Studies By Angi Robinson August 23, 2016 Clinical ResearchPhase 1 - Phase 4 Working with a CRO By Sean Russell August 8, 2016 Previous 1 …48 49 50 51 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today
